Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06119425 · ClinicalTrials.gov registry record · NA
Blood-Based Colorectal Cancer (CRC) Screening Implementation Into Clinical Practice Highlands
A NA study, sponsored by Ballad Health.
- Completed
- Registry status
- NA
- Development phase
- 231
- Enrollment target
NCT06119425 is a NA study that has completed, run by Ballad Health. The registered enrollment target is 231 participants.
The verdict
NCT06119425, a NA study, has completed, sponsored by Ballad Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 231 participants
- Enrollment target
Study Summary
This is a prospective implementation study that will include patients that are identified as being average risk for colorectal cancer (CRC) according to USPSTF guidelines and who have opted to be screened for CRC. The purpose of this study is to understand implementation of a noninvasive screening test in primary care and internal medicine clinical settings, and the impact on patient acceptability and adherence of CRC screening.
Interventions
- DIAGNOSTIC_TEST blood-based CRC screening
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 231 participants |
| Start Date | 2023-10-12 |
| Est. Completion | 2025-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06119425
The ClinicalTrials.gov registry entry for NCT06119425 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 231 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ballad Health, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which blood-based CRC screening is the first listed.
NCT06119425 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06119425 about?
NCT06119425 is a clinical study titled "Blood-Based Colorectal Cancer (CRC) Screening Implementation Into Clinical Practice Highlands". This is a prospective implementation study that will include patients that are identified as being average risk for colorectal cancer (CRC) according to USPSTF guidelines and who have opted to be screened for CRC. The purpose of this study is to understand implementation of a noninvasive screening t...
What is the current status of trial NCT06119425?
This trial is currently completed. It is a NA study. The enrollment target is 231 participants. The study started on 2023-10-12. Estimated completion is 2025-04-30.
What interventions are being tested in trial NCT06119425?
The interventions under investigation include: blood-based CRC screening (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06119425?
This trial is sponsored by Ballad Health, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.